Broor, S; Parveen, S; Maheshwari, M (2018). "Respiratory syncytial virus infections in India: Epidemiology and need for vaccine". Indian Journal of Medical Microbiology. 36 (4): 458–464. PMID30880691. डीओआइ:10.4103/ijmm.IJMM_19_5.
Singh, AK; Wagner, AL; Joshi, J; Carlson, BF; Aneja, S; Boulton, ML (24 July 2017). "Application of the revised WHO causality assessment protocol for adverse events following immunization in India". Vaccine. 35 (33): 4197–4202. PMID28648545. डीओआइ:10.1016/j.vaccine.2017.06.027.
Joshi, J; Das, MK; Polpakara, D; Aneja, S; Agarwal, M; Arora, NK (February 2018). "Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India". Indian Journal of Pediatrics. 85 (2): 139–148. PMID29170922. डीओआइ:10.1007/s12098-017-2532-9.
Singh, AK; Wagner, AL; Joshi, J; Carlson, BF; Aneja, S; Boulton, ML (June 2018). "Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience". Expert Review of Vaccines. 17 (6): 555–562. PMID29865876. डीओआइ:10.1080/14760584.2018.1484285.
Swaminathan, S; Khanna, N (July 2019). "Dengue vaccine development: Global and Indian scenarios". International Journal of Infectious Diseases. 84S: S80–S86. PMID30684747. डीओआइ:10.1016/j.ijid.2019.01.029.
Broor, S; Parveen, S; Maheshwari, M (2018). "Respiratory syncytial virus infections in India: Epidemiology and need for vaccine". Indian Journal of Medical Microbiology. 36 (4): 458–464. PMID30880691. डीओआइ:10.4103/ijmm.IJMM_19_5.
Singh, AK; Wagner, AL; Joshi, J; Carlson, BF; Aneja, S; Boulton, ML (24 July 2017). "Application of the revised WHO causality assessment protocol for adverse events following immunization in India". Vaccine. 35 (33): 4197–4202. PMID28648545. डीओआइ:10.1016/j.vaccine.2017.06.027.
Joshi, J; Das, MK; Polpakara, D; Aneja, S; Agarwal, M; Arora, NK (February 2018). "Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India". Indian Journal of Pediatrics. 85 (2): 139–148. PMID29170922. डीओआइ:10.1007/s12098-017-2532-9.
Singh, AK; Wagner, AL; Joshi, J; Carlson, BF; Aneja, S; Boulton, ML (June 2018). "Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience". Expert Review of Vaccines. 17 (6): 555–562. PMID29865876. डीओआइ:10.1080/14760584.2018.1484285.
Swaminathan, S; Khanna, N (July 2019). "Dengue vaccine development: Global and Indian scenarios". International Journal of Infectious Diseases. 84S: S80–S86. PMID30684747. डीओआइ:10.1016/j.ijid.2019.01.029.